NIKON (7731) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The most important point in this period's results is that the ¥90.63B impairment loss on acquired assets in the Digital Manufacturing Business significantly weighed on performance, causing operating income to turn negative. Revenue was ¥483.91B (-5.6% YoY), operating income was ¥-103.63B (turning to a loss from ¥8.11B in the previous year), and net income was ¥-87.17B (compared with ¥6.31B in the previous year). The gross profit margin excluding the impairment loss remained at 41.1%, indicating that the primary cause of the deterioration in profitability was the reassessment of acquired assets rather than a decline in the business's sales capabilities.

Factors Affecting Performance

【Revenue】Revenue decreased 5.6% YoY to ¥483.91B. Revenue declined in the core Imaging Business to ¥229.0B (-2.8% YoY), in the Precision Equipment Business to ¥104.6B (-16.3%), and in the Healthcare Business to ¥79.0B (-3.1%). Meanwhile, the Components Business increased revenue to ¥51.8B (+5.7%), resulting in divergent performance across businesses.

【Profit and Loss】Operating income fell sharply into negative territory at ¥-103.63B. The largest factor was the ¥90.63B impairment loss related to SLM in the Digital Manufacturing Business (including ¥60.5B in goodwill and ¥26.2B in intangible assets), which should be clearly distinguished as a temporary factor. On a business basis excluding the impairment loss, the Components Business posted a significant increase in operating income to ¥6.6B (+82.0% YoY) owing to the effects of structural reforms, while the Precision Equipment Business also returned to profitability due to gains on the transfer of a business and other factors. In contrast, the Imaging Business recorded operating income of ¥20.9B (-52.2% YoY), a substantial decline, reflecting higher promotional expenses and changes in the product mix. Against profit before tax of ¥-101.86B, net income was ¥-87.17B, with excess income tax refunds of ¥14.69B narrowing the divergence. In conclusion, the company experienced declines in both revenue and profit, while the temporary impairment loss accounted for approximately 87% of the loss.

Segment Analysis

The Imaging Business, which has the largest share of revenue (approximately 47%), is the core business and recorded ¥20.9B in operating income, the only major business to post substantial profitability overall. However, operating income declined 52.2% YoY, due to higher promotional expenses and changes in the product mix. The largest contributor to the fluctuation in performance was the Digital Manufacturing Business, which recorded revenue of ¥16.6B (approximately 3% of the total) but an operating loss of ¥103.4B, effectively depressing consolidated operating income almost in its entirety. Although the Components Business accounts for a small share of revenue, it secured operating income of ¥6.6B and a high profitability rate, demonstrating the significant effects of structural reforms. The Healthcare Business recorded an operating loss of ¥0.6B, affected by stagnant sales in the United States and an increase in provisions.

Key Financial Indicators

Profitability: ROE -15.1%, operating margin -21.4%, net margin -18.0%.
Cash flow quality: OCF/net income was only 0.17x on a calculated basis; however, simple comparison requires caution because the net loss includes the non-cash ¥90.63B impairment loss. FCF was ¥-42.84B.
Investment efficiency: Capital expenditures were ¥24.61B; although depreciation and amortization was not directly disclosed, investing activities as a whole resulted in a cash outflow of ¥28.07B.
Financial soundness: Equity Ratio 52.4% (down from 57.4% in the previous year); the current ratio was approximately 178.5%.

Cash Flow Analysis

Operating CF was ¥-14.77B. Although there was no cash outflow exceeding the net loss, cash-generating capacity was weak. The ¥30.49B increase in inventories was the largest pressure factor, while ¥9.18B in corporate income tax payments and ¥5.97B in lease payments also contributed. Investing CF was ¥-28.07B, primarily due to capital expenditures of ¥24.61B. Financing CF was an inflow of ¥27.32B, with a net increase of ¥51.07B in short-term borrowings serving as the main source of funding and covering dividend payments of ¥16.31B. FCF was ¥-42.84B, indicating a funding shortfall even from OCF and capital expenditures alone. Cash generation assessment: Requires monitoring. If the deterioration in working capital, primarily due to increasing inventories, continues, dependence on borrowings may increase further.

Earnings Quality

Against profit before tax of ¥-101.86B, net income was ¥-87.17B. The divergence was approximately 14% due to excess income tax refunds of ¥14.69B, representing a certain degree of divergence; however, this was attributable to the tax effects associated with recognizing losses. Financial income of ¥7.77B and financial expenses of ¥8.59B were both less than 2% of revenue, limiting the scale of non-operating gains and losses. Although OCF did not fall below net income, the increase in inventories, a non-cash-flow-neutral factor, placed pressure on OCF, making inventory accumulation a key determinant of cash flow quality.

Earnings Forecast and Guidance

The progress rate against the full-year forecast was 71.7% for revenue, slightly below the standard 75%. For operating income/loss, cumulative Q3 results had already reached ¥-103.63B, exceeding the full-year forecast of ¥-100.0B, resulting in a progress rate of 103.6%. The net loss had also reached 102.6% of the full-year forecast of ¥-85.0B, meaning that both operating income and net income would need to turn positive in Q4. The full-year forecast was substantially revised downward in conjunction with these results. The primary reasons for the revision were recognition of the ¥90.63B impairment loss related to SLM and a comprehensive review of the business plan in response to slower growth in the metal 3D printer market and intensifying competition due to the rise of Chinese manufacturers.

Shareholder Returns

The full-year dividend forecast is ¥40.00 per share (Q2 actual: ¥25.00, year-end forecast: ¥15.00), representing a ¥10 downward revision from the previous plan. As the company recorded a net loss for the current period, the payout ratio is merely a formula-derived figure with no meaningful basis in net income. Share buybacks were virtually nonexistent (¥-0.002B), and shareholder returns are centered on dividends. Given FCF of ¥-42.84B, the dividend paid during the current period was funded not by OCF but by borrowings and other financing.

Catalysts

【Short Term】Whether operating income and net income can turn positive in Q4, and whether additional impairment losses will be recognized. Trends in the impact of tariffs (¥7.0B expected for the full year) and foreign exchange (assumption: ¥149).

【Long Term】The policy for balancing short-term earnings recovery and long-term growth investment in the next medium-term management plan scheduled to be announced in May (April 2026–March 2031), and progress in structural reforms targeting the defense and space markets in the Digital Manufacturing Business.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the operating margin and net margin were substantially below the industry median, and relative profitability within the manufacturing sector significantly lagged due to the recognition of the impairment loss.

Growth and Capital Efficiency

Revenue growth was also below the industry median, with the company experiencing a revenue decline in contrast to peers on a growth trajectory.

※Source: Compiled by the company

Risk Factors

1. Inventory accumulation risk: Inventories amounted to ¥351.66B, accounting for 32.0% of total assets, while annualized DIO was approximately 338 days, substantially exceeding the general level for the manufacturing sector. If demand continues to slow, there is a risk of additional valuation losses and discount sales.

2. Risk of monetizing assets after impairment: Although a ¥90.63B impairment loss related to SLM was recognized, the underlying factors include structural changes in the competitive environment, namely slower growth in the metal 3D printer market and the rise of Chinese manufacturers. The key focus will be whether monetization following the structural reforms progresses as planned.

3. Declining cash flow generation: OCF was ¥-14.77B and FCF was ¥-42.84B, indicating that capital expenditures and dividends could not be funded with internal funds and that the company depended on a net increase of ¥51.07B in short-term borrowings. If this situation continues, it may affect the funding structure.

Key Points from the Results

1. Approximately 87% (¥90.63B) of the ¥103.63B operating loss for the current period was attributable to the impairment loss related to SLM, meaning that a one-time accounting treatment had a significant impact on the income statement. The increased profits of the Components Business and Precision Equipment Business excluding the impairment loss indicate the effects of structural reforms.

2. The full-year earnings forecast was substantially revised downward in line with the impairment loss, and the annual dividend was reduced by ¥10 to ¥40. The decision to withhold all bonuses and other compensation for the Chairman and CEO and the President and COO is a notable feature of the earnings disclosure, demonstrating efforts to clarify management responsibility.

3. Annualized DIO of 338 days is far above the general level for the industry. Progress in reducing inventories and the degree of recovery in OCF will therefore be structural observation points affecting the trajectory of financial indicators.

Theoretical Share Price (Reference Value)

Sensitivity: ¥780–¥822 for a ±1% change in the cost of equity, and ¥776–¥816 for a ±0.1 change in ω.

Notes:

• Since forecast ROE is below the cost of equity, the theoretical value will be below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through an integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Nikon’s FY2026 Q3 results were severely loss-making, principally because of a large impairment charge, while underlying trading also weakened. Revenue for the nine months declined 5.6% year on year to ¥483.9bn. Gross profit fell 13.4% to ¥199.1bn, substantially faster than the revenue decline. The gross margin contracted by 370 basis points to 41.1% from 44.9% in the prior-year period. SG&A decreased 3.6% year on year to ¥212.1bn, but remained above gross profit. Operating income deteriorated from a ¥8.1bn profit to a ¥103.6bn loss. The operating margin consequently declined from 1.6% to negative 21.4%, a 2300-basis-point deterioration. The principal driver was a ¥90.6bn impairment loss recognized within operating expenses, versus only ¥1.5bn in the prior-year period. Profit before tax was a ¥101.9bn loss and net income attributable to owners was a ¥87.2bn loss, equivalent to EPS of negative ¥265.03. Finance income of ¥7.8bn nearly offset finance costs of ¥8.6bn, so financing items were not the material cause of the loss. Operating cash flow was negative ¥14.8bn, versus positive ¥39.7bn a year earlier, reflecting particularly large inventory investment. Inventory absorbed ¥30.5bn of cash and other working-capital movements consumed a further ¥8.0bn. Inventory stood at ¥351.7bn, up 14.4% year on year and equal to 32.0% of total assets. Annualized inventory days of 338 are far above the 90-day warning threshold, representing a major operational and cash-conversion concern for a precision-equipment manufacturer. Free cash flow was negative ¥42.8bn after ¥24.6bn of capital expenditure. Equity declined 9.6% year on year to ¥577.6bn, mainly reflecting the period loss and shareholder distributions, although the equity ratio remained a reasonable 52.4%. Full-year guidance implies Q4 revenue of approximately ¥191.1bn and an operating loss of roughly ¥3.6bn, indicating that management expects the impairment-driven loss to be largely booked by Q3, but not a return to operating profitability in Q4. The full-year dividend forecast of ¥40 per share, following the ¥25 interim dividend, implies a ¥15 year-end dividend despite the expected full-year net loss. The near-term analytical focus is therefore on inventory normalization, recovery in gross margin and core operating earnings, and whether the impairment signals a more persistent deterioration in the relevant cash-generating businesses.

Profitability Analysis

The reported annualized DuPont ROE is negative 20.1%, decomposed into a negative 18.0% net profit margin, 0.587x asset turnover, and 1.90x financial leverage. The negative net margin is the overwhelmingly decisive driver of the negative ROE; neither asset turnover nor leverage can compensate for the scale of the loss. Revenue declined 5.6%, while gross profit declined 13.4%, showing that gross-margin compression materially amplified the top-line decline. Gross margin fell to 41.1% from 44.9%, a 370-basis-point decline. SG&A fell 3.6% to ¥212.1bn, which was less than the gross-profit decline, indicating insufficient operating-cost absorption. The main discontinuity was the ¥90.6bn impairment loss recorded in operating expenses, which lifted total other operating expenses to ¥95.7bn from ¥3.5bn. Excluding that impairment mechanically indicates that the reported operating loss is not representative of the cash earnings run rate; however, the pre-impairment operating result would still be only modestly negative at approximately ¥13.0bn, underscoring weak underlying profitability. The annualized EBIT margin of negative 21.4% is materially below the 5% concern threshold and is explicitly flagged as low operating efficiency. The annualized ROIC of negative 20.5% is also materially below the 5% warning threshold, indicating that the current earnings base is not covering the economic cost of the capital employed. The five-factor DuPont tax burden was 0.856 and interest burden was 0.983, confirming that taxation and net interest expense were not the principal sources of earnings deterioration. Finance income and costs were broadly balanced, with net finance cost of only ¥0.8bn. Asset turnover of 0.587x remains restrained by the sizable asset base, particularly inventories, which account for 32.0% of assets. Financial leverage of 1.90x is not excessive in isolation, but it magnifies losses borne by shareholders when operating returns are negative. The impairment is non-recurring in accounting recognition, but it is economically significant because it reflects a reassessment of expected future cash flows from the affected assets or businesses. Sustainable recovery requires both reversal of the elevated inventory burden and restoration of a positive pre-impairment operating margin.

Growth Assessment

Revenue declined 5.6% year on year to ¥483.9bn, indicating a weaker demand and/or product-mix environment during the nine-month period. Gross profit declined more than twice as fast as revenue, pointing to unfavorable mix, pricing, manufacturing-cost absorption, or inventory-related pressure. The 370-basis-point gross-margin decline is important because it preceded the exceptional impairment charge and therefore indicates that underlying profitability weakened as well. Inventory increased 14.4% year on year despite lower revenue, creating a mismatch between production or procurement commitments and sales conversion. The annualized 338 days of inventory is a material quality alert: it is well above both the general manufacturing 90-day warning level and the 60-day efficiency benchmark. Such elevated inventory can lead to future discounting, write-downs, lower factory utilization, and further gross-margin pressure if demand does not recover. The impairment charge of ¥90.6bn may reduce future depreciation or amortization expense, but it also indicates that previous asset carrying values were not supported by updated expected returns. Equity-method investment income was positive at ¥2.6bn, but was not large enough to alter the group-level earnings profile. Full-year revenue guidance of ¥675.0bn indicates 71.7% progress at Q3, 3.3 percentage points below the standard 75% progress rate. The revenue gap is modest and implies a Q4 revenue requirement of approximately ¥191.1bn. Full-year operating-loss guidance of ¥100.0bn has already been exceeded by the Q3 cumulative ¥103.6bn loss, implying a Q4 operating loss improvement of approximately ¥3.6bn. Full-year net-loss guidance of ¥85.0bn is also less negative than the nine-month ¥87.2bn loss, implying modest positive Q4 net income. This guidance profile supports the view that the bulk of impairment recognition occurred by Q3, but it does not yet demonstrate a robust operating recovery. The low 2/10 consistency score reinforces that earnings delivery has been volatile rather than consistently expanding. The main growth validation points are Q4 sales conversion, gross-margin stabilization, inventory reduction, and evidence that post-impairment businesses can generate acceptable returns.

Financial Health

Liquidity remains adequate on reported balance-sheet measures. Current assets were ¥657.5bn against estimated current liabilities of ¥368.4bn, producing a calculated current ratio of approximately 1.78x. This is above the 1.0x warning threshold and above the 1.5x healthy benchmark. Cash and cash equivalents were ¥157.9bn at Q3, down ¥5.7bn during the period before foreign-exchange effects. Inventories of ¥351.7bn comprise more than half of current assets, so liquidity quality depends materially on inventory realizability and normalization rather than cash alone. Interest-bearing bonds and borrowings were ¥244.1bn, comprising ¥127.2bn current and ¥116.9bn non-current borrowings. Current borrowings are covered by current assets, and cash alone exceeds current borrowings by approximately ¥30.8bn, limiting immediate maturity-mismatch risk. The stated debt-to-equity ratio was 0.90x, below the 2.0x aggressive-financing warning level. On a narrower interest-bearing-debt basis, borrowings equal approximately 0.42x total equity, which is also moderate. Finance costs of ¥8.6bn were only marginally greater than finance income of ¥7.8bn, but negative EBIT means that conventional EBIT-based interest coverage is not meaningful and highlights reduced debt-service headroom from operations. Total liabilities increased to ¥522.2bn from ¥471.3bn year on year, while equity fell to ¥577.6bn from ¥639.2bn. The equity ratio consequently declined from 57.4% to 52.4%, but remains supportive of balance-sheet resilience. Retained earnings fell ¥104.7bn, or 20.4% year on year, to ¥408.4bn, primarily reflecting the large loss. Deferred tax assets increased to ¥68.3bn from ¥58.6bn; their recoverability depends on the generation of sufficient future taxable profits. Other financial assets totaled ¥78.7bn on a non-current basis, providing some financial-asset support, while equity-method investments were ¥12.8bn. Lease-related obligations are reflected in part through ¥19.0bn of right-of-use assets and lease payments of ¥6.0bn during the period. Overall solvency is currently sound, but operational underperformance, high inventories, and the impairment signal make preservation of cash and a return to positive operating cash generation key to maintaining that position.

Notable B/S Changes

Retained earnings: -¥104.7bn (-20.4%) to ¥408.4bn — the FY2026 Q3 loss was the principal driver of lower accumulated capital and reduced the equity ratio to 52.4% from 57.4%. Inventories: +¥44.1bn (+14.4%) to ¥351.7bn — inventory rose despite a 5.6% revenue decline and now represents 32.0% of total assets; the associated annualized DIO of 338 days raises cash-conversion, markdown, and further write-down risk. Short-term bonds and borrowings: +¥55.7bn (+78.1%) to ¥127.2bn — increased short-term funding supported cash needs during a period of negative operating cash flow and investment spending; current assets remain sufficient to cover current obligations. Goodwill and intangible assets: -¥71.3bn (-43.1%) to ¥94.2bn — the decline is consistent with the ¥90.6bn impairment loss and reflects a substantial reset of carrying values and expected future cash flows. Deferred tax assets: +¥9.7bn (+16.5%) to ¥68.3bn — the asset has become more material following losses and requires future taxable profits for recovery.

Cash Flow Quality

Cash-flow quality is weak in the current period because operating cash flow turned negative and working capital consumed material cash. Operating cash flow was negative ¥14.8bn, compared with positive ¥39.7bn in the prior-year period. The reported OCF-to-net-income ratio of 0.17x is flagged below the 0.8x quality threshold. Given that net income includes a ¥90.6bn largely non-cash impairment charge, the ratio should not be interpreted as a conventional cash-conversion measure in isolation; nevertheless, both net income and operating cash flow were negative, which confirms a weak cash outcome. The operating cash-flow shortfall was driven primarily by a ¥30.5bn inventory increase. Other working-capital changes consumed another ¥8.0bn, versus a ¥5.3bn source of cash in the prior-year period. These movements are consistent with the 14.4% year-on-year increase in inventories and the annualized 338-day inventory position. The inventory build is the clearest sign of working-capital stress and raises the risk of future markdowns or further write-downs if sales conversion remains slow. The negative accruals ratio of negative 6.6% is not, by itself, a warning-level accrual measure; however, it does not offset the operational concern arising from cash tied up in inventory. Capital expenditure was ¥24.6bn and intangible-asset purchases were ¥14.1bn, taking investing cash outflow to ¥28.1bn. Free cash flow was therefore negative ¥42.8bn. Financing cash flow was positive ¥27.3bn, principally supported by a ¥51.1bn net increase in short-term borrowings, partially offset by bond redemption, long-term debt repayment, dividends, and lease payments. Reliance on short-term borrowing during a period of negative operating cash flow and investment spending is a point to monitor, even though current liquidity remains adequate. Dividends paid totaled ¥16.3bn, adding to cash outflows despite the loss and negative free cash flow. Cash-flow recovery depends most directly on reducing inventory and restoring gross-profit generation rather than on further financing.

Dividend Sustainability

The company paid an interim dividend of ¥25 per share and forecasts a full-year dividend of ¥40 per share, implying a ¥15 year-end dividend. The full-year dividend forecast is not covered by reported earnings because FY2026 Q3 net income attributable to owners was negative ¥87.2bn and full-year guidance is for a negative ¥85.0bn net income. The calculated dividend payout ratio is negative 9.6% because of the loss and is not economically meaningful as a conventional payout measure. More importantly, free cash flow was negative ¥42.8bn and the reported FCF coverage ratio was negative 5.14x. Cash dividends paid during the nine-month period were ¥16.3bn, while share repurchases were immaterial at ¥0.002bn. Accordingly, the relevant capital-return issue is dividend funding rather than buyback intensity. The balance sheet retains ¥157.9bn of cash and a 52.4% equity ratio, allowing the company to maintain a dividend temporarily despite negative free cash flow. However, continued dividends funded through cash balances or incremental short-term borrowings would weaken financial flexibility if inventory remains elevated or operating losses persist. The forecast dividend therefore appears dependent on management’s expectation that the impairment is exceptional and that operating cash flow improves through Q4 and beyond. Dividend durability should be assessed against subsequent inventory release, operating-cash-flow recovery, and the absence of additional restructuring or impairment requirements.

Risk Assessment

Business risks include Demand, product-mix, pricing, or manufacturing-cost pressure is evident in the 5.6% revenue decline and 370-basis-point gross-margin contraction., Annualized inventory days of 338 are exceptionally high for manufacturing. This raises the likelihood of slower sales conversion, discounting, production adjustments, and further inventory valuation losses., The ¥90.6bn impairment charge indicates that expected future cash flows of affected assets or businesses have been reassessed materially downward. Although the accounting charge is largely non-cash, it is a significant signal regarding business-value and execution risk., As a precision-equipment manufacturer, Nikon remains exposed to technology-cycle shifts, customer capital-spending volatility, component availability, currency movements, and product-quality or execution risks..

Financial risks include Operating cash flow of negative ¥14.8bn and free cash flow of negative ¥42.8bn reduce internally generated funding capacity., Financing cash flow relied on a ¥51.1bn increase in short-term borrowings, creating a need to monitor whether working-capital funding becomes more debt-dependent., Negative EBIT means operating earnings do not currently cover finance costs, even though net finance cost was limited to approximately ¥0.8bn., Deferred tax assets of ¥68.3bn require future taxable-profit generation for full realization..

Key concerns include Highest priority: inventory normalization. The 338-day annualized DIO alert has both high likelihood and high potential impact on cash flow, margins, and future impairment risk., Highest priority: return to sustainable pre-impairment operating profitability. Excluding the ¥90.6bn impairment, operating performance was still approximately ¥13.0bn loss-making for the nine-month period., High priority: execution against guidance. Q3 revenue progress was 71.7% versus a standard 75%, while full-year loss guidance requires Q4 losses to be materially smaller than the cumulative Q3 loss., Medium priority: dividend funding. The planned ¥40 per-share annual dividend is unsupported by current-period earnings and free cash flow, although existing liquidity provides temporary capacity., Medium priority: balance-sheet resilience. The 52.4% equity ratio and 1.78x current ratio are currently adequate, but the decline in retained earnings and increase in short-term borrowings warrant monitoring..

Investment Implications

Key takeaways include The FY2026 Q3 loss was dominated by a ¥90.6bn impairment, but the underlying operating profile also weakened through lower revenue, a 370-basis-point gross-margin decline, and an estimated pre-impairment operating loss., The primary operational issue is inventory: inventories increased 14.4% year on year to ¥351.7bn and annualized DIO reached 338 days., Liquidity is presently adequate, with a calculated 1.78x current ratio, ¥157.9bn cash balance, and a 52.4% equity ratio, but cash generation weakened materially., Full-year guidance implies that Q4 should see a much smaller operating loss, consistent with the impairment being principally recognized by Q3; the extent of underlying gross-margin and cash-flow recovery remains the key validation point., The ¥40 per-share full-year dividend forecast is being maintained despite a forecast net loss and negative free cash flow, making future dividend funding capacity an important capital-allocation issue..

Metrics to watch include Inventory balance, annualized inventory days, and the pace of inventory-related operating-cash-flow release, Gross margin and operating margin excluding additional impairment or restructuring items, Q4 revenue delivery versus the approximately ¥191.1bn implied by full-year guidance, Operating cash flow, free cash flow, and reliance on short-term borrowings, Any further impairment, inventory write-down, or restructuring charges, Deferred-tax-asset recoverability and changes in the equity ratio, Confirmation of the ¥40 per-share full-year dividend and the funding source for distributions.

Regarding relative positioning, Nikon’s current profile is characterized by a strong-to-adequate balance sheet but weak earnings and working-capital efficiency. The 41.1% gross margin remains structurally meaningful, yet the negative 21.4% annualized EBIT margin, negative 20.5% annualized ROIC, negative free cash flow, and 338-day annualized inventory position place operating performance well below normal manufacturing efficiency benchmarks. The impairment also makes reported earnings less comparable with periods without such charges; investors should prioritize post-impairment cash earnings, inventory conversion, and margin recovery.